HLN (Haleon) Scaled Net Operating Assets : N/A (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Haleon's operating assets for the quarter that ended in Jun. 2024 was $41,813 Mil. Haleon's operating liabilities for the quarter that ended in Jun. 2024 was $9,963 Mil. Haleon's Total Assets for the quarter that ended in Mar. 2024 was $0 Mil. Therefore, Haleon's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was N/A.

Haleon Scaled Net Operating Assets Historical Data

The historical data trend for Haleon's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Scaled Net Operating Assets Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.78

0.76

0.79

0.70

0.75

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Haleon's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Haleon's Scaled Net Operating Assets falls into.

Haleon Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Haleon's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(41849.367	-	9962.025)	/	42405.603
=	0.75

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	43107.595	-	1258.228
=	41849.367

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	21931.646	-	11139.241	-	830.38
=	9962.025

Haleon's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Mar. 2024 )
=	(41812.977	-	9963.104)	/	0
=	N/A

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	42488.55	-	675.573
=	41812.977

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	21232.824	-	9423.664	-	1846.056
=	9963.104

Haleon Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Haleon's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.